Mammary Cell News Volume 15.09 | Mar 09 2023

    0
    56








    2023-03-09 | MCN 15.09


    Mammary Cell News by STEMCELL Technologies
    Vol. 15.09 – 9 March, 2023
    TOP STORY

    Dynamic Bioinspired Coculture Model for Probing ER+ Breast Cancer Dormancy in the Bone Marrow Niche

    To study underlying cell-cell interactions between dormant disseminated tumor cells and bone lining cells, researchers established a bioinspired dynamic indirect coculture model of estrogen receptor–positive (ER+) breast cancer cells with bone marrow niche cells, human mesenchymal stem cells, and fetal osteoblasts.
    [Science Advances]

    Full Article
    New human primary cancer-sourced blood products, immune cell subsets, and more. Click to view products.
    PUBLICATIONSRanked by the impact factor of the journal

    State- and Stimulus-Specific Dynamics of SMAD Signaling Determine Fate Decisions in Individual Cells

    Investigators systematically investigated how SMAD-mediated responses were modulated by various ligands of the transforming growth factor β family and compared these ligand responses in quiescent and proliferating MCF10A cells.
    [Proceedings Of The National Academy Of Sciences Of The United States Of America]

    Abstract

    OBSCN Restoration via OBSCN-AS1 Long-Noncoding RNA CRISPR-Targeting Suppresses Metastasis in Triple-Negative Breast Cancer

    The authors showed that OBSCN-Antisense RNA 1 (OBSCN-AS1), a novel nuclear long-noncoding RNA gene originating from the minus strand of OBSCN, and OBSCN displayed positively correlated expression and were downregulated in breast cancer biopsies.
    [Proceedings Of The National Academy Of Sciences Of The United States Of America]

    Abstract

    Targeting TACC3 Represents a Novel Vulnerability in Highly Aggressive Breast Cancers with Centrosome Amplification

    Researchers identified transforming acidic coiled-coil containing protein 3 (TACC3) to be overexpressed in tumors with centrosome amplification, and its high expression was associated with dramatically worse clinical outcome.
    [Cell Death & Differentiation]

    Full Article

    Tspan6 Stimulates the Chemoattractive Potential of Breast Cancer Cells for B Cells in an EV- and LXR-Dependent Manner

    Gene expression profiling identified the liver X receptor (LXR)-dependent transcriptional network as a key pathway that controlled both cancer cell-derived extracellular vesicle-induced migration of B cells and accumulation of B cells in breast cancer tissues.
    [Cell Reports]

    Full Article

    TGFβ-Mediated MMP13 Secretion Drives Myoepithelial Cell Dependent Breast Cancer Progression

    To understand the role of the normally tumor suppressive myoepithelial cell in disease progression, investigators presented a three-dimensional (3D) in vitro model incorporating both luminal and myoepithelial cells in physiomimetic conditions.
    [npj Breast Cancer]

    Full Article

    The Inhibitory Effect and Mechanism of Resina Draconis on the Proliferation of MCF-7 Breast Cancer Cells: A Network Pharmacology-Based Analysis

    To explore the potential mechanism of Resina Draconis (RD) against breast cancer (BC) using network pharmacology and experimental validation, data on bioactive compounds, potential targets of RD, and related genes of BC were obtained from multiple public databases.
    [Scientific Reports]

    Full Article

    ACAT1-Mediated METTL3 Acetylation Inhibits Cell Migration and Invasion in Triple Negative Breast Cancer

    Methyltransferase like-3 (METTL3) was found to be downregulated in TNBC cells via qPCR and western blot analyses. Co-immunoprecipitation and GST pulldown assays revealed the interaction between acetyl-CoA acetyltransferase 1 (ACAT1) and METTL3.
    [Genes And Immunity]

    AbstractGraphical Abstract

    Chemokine (C-C Motif) Ligand 2 Is Regulated through the EGFR/Src Pathway in HER2-Positive Breast Cancer Cells

    A human cytokine array was performed to investigate the differential expression of cytokines by human epidermal growth factor receptor 2 (HER2) overexpression. qRT- PCR, enzyme-linked immunosorbent assay, and western blot were performed to detect the levels of mRNA and protein expression.
    [Anticancer Research]

    Abstract

    Isophysalin a Inhibits the Stemness of Breast Cancer Cells Possibly via Stat3 and IL-6 Signaling

    The effect of isophysalin A on breast cancer stem cells was examined using a mammosphere formation, a colony formation, and a cell migration assay, as well as CD44 analysis, an apoptosis assay, qRT- PCR, western blotting, an electrophoretic mobility shift assay, and a cytokine profiling assay.
    [Anticancer Research]

    Abstract
    Subscribe to Organoid News to stay current with the latest organoid research.
    REVIEWS

    Differences between Zoledronic Acid and Denosumab for Breast Cancer Treatment

    Zoledronic acid and denosumab are bone-modifying agents that have different anticancer activities, and they may be associated with the improvement of survival of breast cancer patients under different mechanisms.
    [Journal of Bone and Mineral Metabolism]

    Abstract
    INDUSTRY AND POLICY NEWS

    Cancer Will Cost the World $25 Trillion over Next 30 Years

    The total cost of cancer to the global economy will reach 25.2 trillion international dollars between 2020 and 2050, according to an analysis of 29 cancers across 204 countries.
    [Nature]

    Press Release
    FEATURED EVENT

    Genomics of Rare Disease

    April 24 – 26, 2023
    Hinxton, England, United Kingdom

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Fellowship – Breast Cancer

    Harvard Medical School – Boston, Massachusetts, United States

    Assistant Professor – Breast Cancer Biology

    University of Alberta – Edmonton, Alberta, Canada

    Research Assistant Professor – Urology

    University of Miami – Miami, Florida, United States

    Postdoctoral Researcher – Type III Collagen

    Penn Medicine – Philadelphia, Pennsylvania, United States

    Bioinformatician – Breast Cancer Mutagenesis

    University of Texas Health Science Center – San Antonio, Texas, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Mammary Cell News Twitter